Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Seres Therapeutics to Announce Third Quarter 2023 Results on Thursday, November 2, 2023; Host Conference Call and Webcast at 8:00 a.m. EST


Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced that it will release third quarter 2023 financial results on Thursday, November 2, 2023. Management will host a conference call with investors to discuss the results and corporate updates at 8:00 a.m. ET.

The conference call may be accessed by calling 1-866-777-2509 (international callers dial 1-412-317-5413). Participants may pre-register for the conference call at https://dpregister.com/sreg/10184132/faf729b9c0

To join the live webcast, please visit the "Investors and News" section of the Seres website at www.serestherapeutics.com.

A webcast replay will be available on the Seres website beginning approximately two hours after the event and will be archived for approximately 21 days.

About Seres Therapeutics

Seres Therapeutics, Inc. (Nasdaq: MCRB) is a commercial-stage company developing novel microbiome therapeutics for serious diseases. Seres' lead program, VOWSTtm, obtained U.S. FDA approval in April 2023 as the first orally administered microbiome therapeutic to prevent recurrence of C. difficile infection (CDI) in adults following antibacterial treatment for recurrent CDI and is being commercialized in collaboration with Nestlé Health Science. Seres is evaluating SER-155 in a Phase 1b study in patients receiving allogeneic hematopoietic stem cell transplantation. The Company is also conducting research to inform further development of microbiome therapeutics for ulcerative colitis. For more information, please visit www.serestherapeutics.com.


These press releases may also interest you

at 20:07
Ascentage Pharma Received US$100 Million Option Payment from Takeda
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
SD Networks Set Framework for Asia Pacific Modernization
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics To Participate at the Stifel Virtual Cell Therapy Forum
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...

at 18:46
BOXABL Investors Have Now Indicated They Want to Invest Over $10MM in the Current Stock Offering! BOXABL Previously Sold Out the Reg A Crowdfund
BOXABL, the innovative housing startup known for its foldable Casita homes and building technology, has announced this week that investors have indicated they want to invest over $10MM in the current stock offering. BOXABL previously SOLD OUT the Reg...

at 18:40
Ryan Lawsuit Halts Federal Trade Commission (FTC) Ban on Non-Compete Agreements
Today, a federal court ruled for Ryan (a leading global tax services and software provider) and against the U.S. Federal Trade Commission (FTC), halting the FTC's ban on non-compete agreements set to take effect this fall. U.S. District Court Judge...

at 17:45
Automotive Battery Testers Market size is set to grow by USD 78.9 million from 2024-2028, Increasing lifespan of vehicles leading to growth in vehicle population to boost the market growth, Technavio
The global automotive battery testers market  size is estimated to grow by USD 78.9 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 3.73%  during the forecast period.  Increasing lifespan of...

More news about Science and technology...


News published on and distributed by: